Showing results (21-30 of 353) with videos related to
Sort By:
Pageof 36
Movement Disorders : Official Journal of the Movement Disorder Society|February 9, 2002
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapyDirk Dressler, Hans BigalkeDisability and Rehabilitation|November 23, 2007
Botulinum toxin treatment of axial and cervical dystoniaReiner Benecke, Dirk DresslerBiologics : Targets & Therapy|January 7, 2011
Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?Jürgen Frevert, Dirk DresslerExpert Review of Neurotherapeutics|November 18, 2016
Immunological aspects of botulinum toxin therapyDirk Dressler, Hans BigalkeDisability and Rehabilitation|November 23, 2007
Pharmacology of therapeutic botulinum toxin preparationsDirk Dressler, Reiner BeneckeJournal of Neural Transmission (Vienna, Austria : 1996)|December 11, 2012
Interdisziplinärer Arbeitskreis Bewegungsstörungen (IAB): an interdisciplinary working group for promoting multimodal therapy of movement disordersFereshte Adib Saberi, Dirk DresslerJournal of Neural Transmission (Vienna, Austria : 1996)|August 1, 2020
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohortDirk Dressler, Fereshte Adib SaberiEuropean Neurology|January 15, 2005
Botulinum toxin: mechanisms of actionDirk Dressler, Fereshte Adib SaberiJournal of Neural Transmission (Vienna, Austria : 1996)|October 18, 2016
Safety of botulinum toxin short interval therapy using incobotulinumtoxin ADirk Dressler, Fereshte Adib SaberiJournal of Neural Transmission (Vienna, Austria : 1996)|December 21, 2013
Botulinum toxin in myotonia congenita: it does not help against rigidity and painDirk Dressler, Fereshte Adib SaberiPageof 36